Cancer stem cells

Open Access
C1orf50 Drives Malignant Melanoma Progression Through the Regulation of Stemness
YUSUKE OTANI, MASAKI MAEKAWA, ATSUSHI TANAKA, TIRSO PEÑA, VANESSA D. CHIN, ANNA ROGACHEVSKAYA, SHINICHI TOYOOKA, MICHAEL H. ROEHRL and ATSUSHI FUJIMURA

Cancer Genomics & Proteomics July 2025, 22 (4) 510-524; DOI: https://doi.org/10.21873/cgp.20518
Open Access
Correlation of GD2 Biosynthesis Enzymes With Cancer Stem Cell Markers in Human Breast Cancer
NIAMH S. O’NEILL, MARIAM RIZK, AMBER X. LI, TRACEY A. MARTIN, WEN G. JIANG and KEFAH MOKBEL

Cancer Genomics & Proteomics March 2025, 22 (2) 231-246; DOI: https://doi.org/10.21873/cgp.20498
Open Access
ILK Expression in Colorectal Cancer Is Associated with EMT, Cancer Stem Cell Markers and Chemoresistance
DIMITRIOS TSOUMAS, SOFIA NIKOU, EFSTATHIA GIANNOPOULOU, SPYRIDON CHAMPERIS TSANIRAS, CHAIDO SIRINIAN, IOANNIS MAROULIS, STAVROS TARAVIRAS, VASSILIKI ZOLOTA, HARALABOS P. KALOFONOS and VASILIKI BRAVOU

Cancer Genomics & Proteomics March 2018, 15 (2) 127-141;
Open Access
Chemical Proteomic Approaches Targeting Cancer Stem Cells: A Review of Current Literature
HYE JIN JUNG

Cancer Genomics & Proteomics September 2017, 14 (5) 315-327;
Open Access
Transcriptome Analysis of CD133-positive Stem Cells and Prognostic Value of Survivin in Colorectal Cancer
SEUNG TAE KIM, INSUK SOHN, IN-GU DO, JIRYEON JANG, SEOK HYUNG KIM, SIN HO JUNG, JOON OH PARK, YOUNG SUK PARK, AMIRALI TALASAZ, JEEYUN LEE and HEE CHEOL KIM

Cancer Genomics & Proteomics September 2014, 11 (5) 259-266;

Main menu

User menu

Search

Cancer stem cells